"Pancreatectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical removal of the pancreas. (Dorland, 28th ed)
| Descriptor ID |
D010180
|
| MeSH Number(s) |
E04.210.752
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pancreatectomy".
Below are MeSH descriptors whose meaning is more specific than "Pancreatectomy".
This graph shows the total number of publications written about "Pancreatectomy" by people in this website by year, and whether "Pancreatectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 9 | 5 | 14 |
| 2018 | 14 | 10 | 24 |
| 2019 | 9 | 3 | 12 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Pancreatectomy" by people in Profiles.
-
Effects of COVID-19 Pandemic on the Treatment of Pancreatic Cancer: A Perspective from Central Europe. Dig Surg. 2021; 38(2):158-165.
-
HPB surgery in the time of COVID. Br J Surg. 2020 11; 107(12):e588-e589.
-
Coronavirus Disease 2019 Pandemic: Potential Collateral Damage on Patients With Operable Pancreatic Cancer. Pancreas. 2020 08; 49(7):e61-e62.
-
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19). Dig Surg. 2020; 37(6):524-526.
-
Textbook Outcomes Among Medicare Patients Undergoing Hepatopancreatic Surgery. Ann Surg. 2020 06; 271(6):1116-1123.
-
Short-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis. Surg Endosc. 2020 09; 34(9):3927-3935.
-
ASO Author Reflections: Formalization of Robotic Central Pancreatectomy Focusing on the Reconstruction of Pancreatic Digestive Continuity. Ann Surg Oncol. 2019 12; 26(Suppl 3):707-708.
-
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma. Carcinogenesis. 2019 08 22; 40(8):947-955.
-
ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Ann Surg Oncol. 2019 12; 26(Suppl 3):610-611.
-
Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group. J Surg Oncol. 2019 Aug; 120(2):231-240.